Atossa Therapeutics
ATOS
#9205
Rank
โ‚น9.61 B
Marketcap
โ‚น74.46
Share price
-8.82%
Change (1 day)
-23.68%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚น2.45 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.31 Billion, an increase over its 2023 earnings that were of -โ‚น2.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.45 Billion6.29%
2024 -โ‚น2.31 Billion-15.25%
2023 -โ‚น2.72 Billion11.62%
2022 -โ‚น2.44 Billion30.84%
2021 -โ‚น1.86 Billion15.58%
2020 -โ‚น1.61 Billion3.41%
2019 -โ‚น1.56 Billion51.16%
2018 -โ‚น1.03 Billion40.41%
2017 -โ‚น0.74 Billion27.54%
2016 -โ‚น0.58 Billion-47.49%
2015 -โ‚น1.1 Billion-17.25%
2014 -โ‚น1.33 Billion35.91%
2013 -โ‚น0.98 Billion112.3%
2012 -โ‚น0.46 Billion46.53%
2011 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.923 T-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น120.32 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น116.15 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.71 Billion-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.76 B-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.86 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA